These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3356206)

  • 41. Plasma levels of soluble CD8 antigen and interleukin-2 receptor antigen in patients with hairy cell leukemia, relationship with splenectomy and with clinical response to therapy.
    Ho AD; Grossmann M; Knauf W; Martin H; Trümper L; Zwingers T; Sonnen R; Pralle H; Hunstein W
    Leukemia; 1989 Oct; 3(10):718-23. PubMed ID: 2506398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human lymphoblastoid interferon for hairy cell leukemia: results from the Italian Cooperative Group.
    Damasio EE; Bernasconi C; Castoldi GL; Chisesi T; Federico M; Lamparelli T; Lauria F; Pagnucco G; Resegoti L; Rossi E
    Leukemia; 1987 Apr; 1(4):331-3. PubMed ID: 3669757
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia.
    Bardawil RG; Ratain MJ; Golomb HM; Bitter MA; Groves C; Vardiman JW
    Leukemia; 1987 Apr; 1(4):340-3. PubMed ID: 3669760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hairy cell leukemia. An update on a cohort of 93 patients treated in a single institution. Effects of interferon in patients relapsing after splenectomy and in patients with or without maintenance treatment.
    Troussard X; Flandrin G
    Leuk Lymphoma; 1994; 14 Suppl 1():99-105. PubMed ID: 7820062
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Should alpha interferon be used as primary treatment for hairy cell leukemia? Italian Cooperative Group for Hairy Cell Leukemia.
    Capnist G; Federico M; Chisesi T; Resegotti L; Pagnucco G; Castoldi GL; Lamparelli T; Frassoldati A; Guarnaccia C; Leoni P
    Leuk Res; 1991; 15(6):419-26. PubMed ID: 1861528
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recombinant alpha-2 interferon for treatment of hairy cell leukemia without prior splenectomy.
    Ehmann WC; Silber R
    Am J Med; 1986 Jun; 80(6):1111-4. PubMed ID: 3728508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recombinant alpha-2 interferon in the treatment of hairy cell leukemia.
    Thompson JA; Brady J; Kidd P; Fefer A
    Cancer Treat Rep; 1985; 69(7-8):791-3. PubMed ID: 4016788
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hairy cell leukemia: bone marrow changes following splenectomy and alpha-interferon therapy.
    Pangalis GA; Kittas C; Viniou N; Kokkinou S; Variamis H; Paizis P; Melanthiou F; Fessas P
    Leukemia; 1987 Apr; 1(4):343-6. PubMed ID: 3669761
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Recombinant (IFN-alpha 2b) therapy in hairy cell leukemia].
    Schwarzmeier JD; Wagner L; Prischl F; Schwabe M; Lion T; Micksche M; Köller U; Bernhart M; Fritz O; Seewann HL
    Klin Wochenschr; 1987 Jul; 65(14):699-705. PubMed ID: 3114550
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Alpha interferon treatment of patients with hairy-cell leukaemia.
    Hagberg H; Alm G; Björkholm M; Glimelius B; Killander A; Simonsson B; Sundström C; Ahre A
    Scand J Haematol; 1985 Jul; 35(1):66-70. PubMed ID: 4048862
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Durability of responses to interferon alfa-2b in advanced hairy cell leukemia.
    Ratain MJ; Golomb HM; Bardawil RG; Vardiman JW; Westbrook CA; Kaminer LS; Lembersky BC; Bitter MA; Daly K
    Blood; 1987 Mar; 69(3):872-7. PubMed ID: 3814819
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peripheral and intrasplenic platelet kinetics and bone marrow megakaryopoiesis in alpha-2b-interferon treated hairy cell leukemia.
    Wadenvik H; Braide I; Ridell B; Kutti J; Jacobsson S; Revesz P
    Leuk Res; 1994 Aug; 18(8):569-75. PubMed ID: 8065159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interferon alpha-2 for hairy cell leukemia: evidence for induction of RNA synthesis in hairy cells and failure to correlate enhancement of natural killer cells with elimination of hairy cells.
    Schwarzmeier JD; Schwabe M; Prischl F; Wagner L; Lion T; Micksche M; Köller U
    Eur J Haematol; 1987 Nov; 39(5):418-25. PubMed ID: 3691760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Strategy for the treatment of hairy cell leukemia.
    Porzsolt F; Raghavachar A; Digel W; Raghavachar A; Bartram CR; Heimpel H
    Leukemia; 1987 Apr; 1(4):334-7. PubMed ID: 3669758
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The treatment of hairy cell leukemia with recombinant alfa interferon: a multi-institutional study.
    Thompson JA; Fefer A
    Invest New Drugs; 1987; 5 Suppl():S5-8. PubMed ID: 3298134
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The treatment of hairy cell leukemia with alpha 2b-interferon: experience with 27 patients treated more than one year.
    Thompson JA; Rubin E; Fefer A
    Leukemia; 1987 Apr; 1(4):328-30. PubMed ID: 3669756
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Early response to alpha interferon in a patient affected by hairy cell leukemia.
    Di Raimondo F; Murolo D; Milone G; Cacciola E; Giustolisi R
    Haematologica; 1992; 77(4):355-6. PubMed ID: 1427445
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hairy cell leukemia variant: a morphologic, immunologic and clinical study of 7 cases.
    Zinzani PL; Lauria F; Buzzi M; Raspadori D; Gugliotta L; Bocchia M; Macchi S; Algeri R; Tura S
    Haematologica; 1990; 75(1):54-7. PubMed ID: 2338288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of alpha-interferon on the immune system of patients with hairy cell leukemia.
    Foa R; Fierro MT; Lusso P; Bonferroni M; Raspadori D; Buzzi M; Zinzani PL; Resegotti L; Lauria F
    Leukemia; 1987 Apr; 1(4):377-9. PubMed ID: 3499543
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alpha-interferon in hairy cell leukaemia: direct effects on hairy cells or indirect cytotoxicity?
    Sigaux F; Castaigne S; Lehn P; Dupuy E; Billard C; Gluckman JC; Boiron M; Falcoff E; Flandrin G; Degos L
    Int J Cancer Suppl; 1987; 1():2-8. PubMed ID: 3476473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.